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Dormant pathogenic CD4+ T cells are prevalent in
the peripheral repertoire of healthy mice
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Thymic central tolerance eliminates most immature T cells with autoreactive T cell receptors
(TCR) that recognize self MHC/peptide complexes. Regardless, an unknown number of
autoreactive CD4+Foxp3− T cells escape negative selection and in the periphery require
continuous suppression by CD4+Foxp3+ regulatory cells (Tregs). Here, we compare immune
repertoires of Treg-deficient and Treg-sufficient mice to find Tregs continuously constraining
one-third of mature CD4+Foxp3− cells from converting to pathogenic effectors in healthy
mice. These dormant pathogenic clones frequently express TCRs activatable by ubiquitous
autoantigens presented by class II MHCs on conventional dendritic cells, including self-
peptides that select them in the thymus. Our data thus suggest that identification of most
potentially autoreactive CD4+ T cells in the peripheral repertoire is critical to harness or
redirect these cells for therapeutic advantage.
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The current paradigm proposes that in healthy individuals,peripheral CD4+ T cells rarely become autoreactivebecause most thymocytes expressing αβTCRs (TCRs)
which bind self MHC/peptide complexes with moderate to high
affinity are eliminated by thymic negative selection1–4. Alter-
natively, thymocytes that express potentially autoreactive TCRs
are directed to CD4+Foxp3+ or CD4+CD8αα+ T cell lineages or
rendered unresponsive by mechanisms of peripheral tolerance5.
In contrast, several reports investigating the effectiveness of
negative selection by different model autoantigens concluded that
a significant portion of autoreactive CD4+ cells escape to the
periphery, although pathogenicity of these cells in vivo has not
been examined6,7. The frequency of self-reactive CD4+ cells
appears to be inversely proportional to the abundance of the
relevant selecting autoantigen in the thymus8, but global identi-
fication and quantification of most self-reactive, mature CD4+
cells present in the peripheral repertoire remains a challenge.
Finding potentially autoreactive CD4+ cells in healthy indivi-
duals is also a challenging task because mechanisms of peripheral
tolerance including anergy, expression of inhibitory co-receptors
and suppression mediated by Tregs continuously sustain quies-
cence of self-reactive T cells. Thus, it is not surprising that
blockade of inhibitory receptors on T cells or depletion of Tregs
precipitate autoimmunity9,10, revealing a potential risk of clinical
approaches which, in order to improve immune response to
infection or cancer, attempt to weaken peripheral tolerance
mechanisms11,12. Acute course of fatal autoimmunity in mice and
humans with congenital Foxp3 defects also implies that an
abundance of autoreactive CD4+Foxp3− cells and diversity of
their TCRs may need to be re-examined to better understand the
pathogenesis of autoimmune diseases.
Several studies have attempted to identify CD4+ cells expres-
sing potentially autoreactive TCRs in healthy mice and to reveal
their self-reactivities by compromising peripheral tolerance.
Experiments in which Tregs were deleted using aCD25 MoAb or
diphtheria toxin (DT) concluded that the proportion of auto-
reactive CD4+ clones in the normal repertoire detected by an
increase in expression of CD69, Nur77GFP or measuring expan-
sion of autoreactive T cell clones is around 4%13–16. In other
reports, the ablation of Tregs by DT in specific pathogen-free
(SPF) or germ-free adult mice led to rapid onset of lethal auto-
immunity, demonstrating that many peripheral CD4+Foxp3−
cells can be activated by tissue-derived autoantigens unless these
cells are stopped by Tregs17,18.
Here we report that in adult, healthy C57BL/6 mice one-third
of CD4+Foxp3− T cells express autoreactive TCRs that can be
activated by ubiquitous self-peptides presented by autologous
DCs. Normally, these cells pathogenic autoreactivity is con-
strained by Tregs, but when Tregs are dysfunctional or ablated it
changes CD4+Foxp3−cells activation threshold for self-peptides.
We propose that common selection by agonist self-peptides and
limited intrathymic deletion enrich peripheral repertoire of
CD4+Foxp3− cells in many dormant autoreactive clones that in
suitable conditions can cause autoimmunity.
Results
Scurfy (Sf) mice with restricted αβTCR repertoire succumb to
autoimmunity. Sf mutant mice lack functional Tregs and develop
lethal autoimmunity driven by polyclonally activated CD4+
cells19. The identities of autoreactive CD4+ clones exclusive to the
Sf strain versus those shared with healthy mice have not been
investigated. This analysis can be achieved by comparing auto-
reactive TCRs on peripheral CD4+Foxp3− cells in Sf mice with
TCRs expressed by cells with activated phenotype present in
healthy mice. To ensure that we could analyze cells expressing the
same set of TCRs, we used TCRmini mice where TCRs diversity is
reduced approximately by two orders of magnitude (from 107 of
different TCRs in wild type mice20 to ~105 in our strains).To
compare TCR repertoires, we first backcrossed SfC57BL/6 to
TCRα− mutant mice, and then to TCR transgenic mice expres-
sing a single, rearranged Vβ14Jβ2.6 chain paired with different,
transgenic TCRα chains formed by natural rearrangements of
single Vα2.9 segment to one of the two Jα segments (Jα2/Jα26). In
these mice, a semi-diverse TCR repertoire supports natural thy-
mocyte differentiation to CD8+, CD4+Foxp3− and Foxp3+
lineages and CD4+ cells respond to various antigens21. We
further crossed SfTCRmini mice with C57BL/6Foxp3GFP (now
referred to as SfTCRmini or TCRmini mice) or C57BL/6Nur77GFP
reporter strains, in which GFP expression labels Tregs or reflects
TCR functional affinity for self-antigen(s), respectively22,23. In the
SfTCRminiFoxp3GFP model, dysfunctional Tregs can be separated
from activated, CD4+Foxp3GFP− cells; in SfTCRminiNur77GFP
mice, autoimmune effectors can be categorized according to their
TCR signal strength.
Figure 1a shows that SfTCRmini mice develop lethal auto-
immunity by 7–10 weeks of age, and 6-week-old SfTCRmini mice
suffer from lymphadenopathy, splenomegaly, and numerous
infiltrates of CD4+ cells in the lungs, liver, and skin (Fig. 1b).
In various organs isolated from SfTCRmini mice, 65–85% of
CD4+Foxp3GFP− cells (SfFoxp3GFP−) showed an activated
CD44+CD62L− phenotype and elevated expression of the
proliferation marker CD71 (Fig. 1c, d, Supplementary Fig. 1a).
Overall, polyclonal activation of CD4+ cells in SfTCRmini mice
increased the total number of CD4+ cells compared to TCRmini
controls (Fig. 1e), whereas the proportions of CD4+ cells with
reporter Foxp3GFP+ (SfFoxp3GFP+) resembled proportions of
CD4+Foxp3GFP+ cells in healthy mice (with the exception of
colon where their proportion was lower) (Fig. 1f, g). Ultimately,
all SfTCRmini mice developed clinical symptoms of fulminating
autoimmune syndrome manifested by runting, exfoliative der-
matitis and wasting disease. Together these results show that
SfTCRmini mice develop multi-organ autoimmunity that resem-
bles disease in original SfC57BL/6 mice and that TCRmini mice
need functional Tregs to sustain self-tolerance.
CD4+Foxp3− cells from Sf and healthy mice share many TCRs.
The relationship between autoreactive CD4+ clones in Sf mice and
peripheral CD4+ cells in healthy mice remains unknown. This is in
part because thymic atrophy in Sf mice supports the release of self-
reactive CD4+ cells, and proinflammatory cytokines expand rare
autoreactive clones24. Alternatively and not mutually exclusive,
when Tregs are disabled, a substantial portion of naive CD4+
Foxp3GFP− cells (which are also present in healthy mice) become
activated by self-antigens17. We examined TCRs expressed by
activated CD4+ clones in SfTCRmini mice and compared them
to TCRs on CD4+ cells from healthy TCRmini mice. For this
purpose, we used high throughput sequencing (HTS) that exam-
ined over 4 × 106 of TCRα CDR3 regions from each TCRmini strain
studied. This approach showed that most of dominant TCRα
CDR3 regions retrieved from SfFoxp3GFP− effectors (CD4+CD44+
CD62L−) were also found on Foxp3GFP− clones in healthy mice
(Fig. 2a, Supplementary Fig. 2), and the shared portion was similar
when respective repertoires of CD4+Foxp3GFP+ cells were com-
pared (Fig. 2b, Supplementary Fig. 2). The substantial overlap
of TCRs expressed by CD4+ cells from SfTCRmini and TCRmini
mice was also confirmed using single-cell TCR sequencing (Sup-
plementary Fig. 3). To examine the global similarity between these
repertoires, we applied the Mutual Information Index (MII) which
assigns a value of 1 to a pair of completely overlapping repertoires
(containing identical TCRs abundance patterns) and value of 0 to
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pairs with entirely non-overlapping patterns25. The values of this
index for repertoire of CD4+Foxp3GFP− subsets ranged from 0.3 to
0.7, demonstrating a significant overlap of both repertoires
(Fig. 2c). Approximately 25% TCRs were not found in the TCRmini
repertoire, suggesting that Tregs-deficiency also supports an
expansion of strain-specific clones. To compare the diversity of
TCRs on CD4+ cells from Sf and control TCRmini mice, we utilized
the Renyi Entropy Function (REF). REF analyzes the diversity of
TCRs considering unseen species and adjusts for the abundance of
specific TCRs. A REF value of <1 gives more weight to the rare
TCRs contributing to the repertoire, whereas a REF value of greater
than 1 gives more weight to the abundant TCRs25. The REF cal-
culated here shows that the overall SfCD4+ repertoire was more
heterogeneous than the corresponding repertoire in healthy mice
likely due to an influx of low-abundance clones (Fig. 2d).
SfCD4+ cells exhibit exaggerated reactions to self-antigens.
Since many CD4+Foxp3GFP− cells from TCRmini and SfTCRmini
mice expressed mutual TCRs but only the latter strain developed
autoimmunity, we investigated ex vivo autoreactivity of individual
TCRs. For this purpose, we sorted activated CD4+Foxp3GFP−
cells from both strains, produced CD4+TCR+ hybridomas and
studied their activation by bone marrow-derived dendritic cells
(DCs) from C57BL/6 mice. We measured TCR driven hybrido-
mas activation by examining IL-2 production and fold increase
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Fig. 1 SfTCRmini mice develop multiorgan disease as original Sf mice. a Survival curves of SfC57BL/6 and SfTCRmini mice and respective healthy strains
(Kaplan–Meier curves and log-rank test; n= 7–16 per group). b Photomicrographs of H&E stained histological sections of various organs from SfTCRmini
(upper panel) and TCRmini mice (lower panel). For each strain, 3–6 mice were examined and each symbol represents the individual animal. Scale
bar 400 μm. c, d Proportions of CD4+Foxp3GFP−CD44+CD62L− cells in lymphoid and non-lymphoid organs. e Total number of CD4+ cells and f,
g proportions of CD4+Foxp3GFP+ cells in indicated organs. All mice were 6–8 weeks old, each dot on graphs represents one mouse (n= 5–10). Unpaired
t-test was applied, and statistical significance is indicated where appropriate (*p < 0.05, **p < 0.01, ***p < 0.001, NS-not significant). Mean ± SD is shown
for each sample. Source data is provided in a Source Data file
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Sf TCRmini Foxp3GFP– vs TCRmini Foxp3GFP–

































Fig. 2 CD4+ cells from SfTCRmini and TCRmini mice share many αβTCRs. a Frequencies of 50 dominant TCRs on CD4+Foxp3GFP− (blue heatmap) or
b Foxp3GFP+ (red heatmap) cells from each indicated organ (sequences see Supplementary Data 1a, b). c Similarity indices (MII) of TCRs expressed by
CD4+Foxp3GFP− (upper panel) or CD4+Foxp3GFP+ (lower panel) cells among individual SfTCRmini (white bars) or TCRmini (gray bars) mice or cross-
compared among both strains (blue and red bars). d Diversity (REF) calculated for repertoires of CD4+Foxp3GFP− (or Foxp3GFP+) cells from Sf or control
mice. Repertoires from three individual mice from each strain were sequenced. Source data are provided in a Source Data file. Error bars depict SD
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hybridomas (621 from Sf and 252 from control CD4+Foxp3GFP−
cells) did not constitutively make IL-2, had comparable expres-
sion of CD4 or TCR and expressed only a basal level of the
Nur77GFP reporter (Supplementary Fig. 4). However, all hybri-
domas reproducibly made IL-2 and expressed GFP when incu-
bated overnight on aCD3 MoAb coated plastic plates
(Supplementary Fig. 5a). Significantly, ~37% of the hybridomas
established from SfCD4+Foxp3GFP− cells produced IL-2 and
elevated Nur77GFP expression following overnight co-culture with
C57BL/6 DCs, whereas less than 0.5% of hybridomas from
healthy TCRmini mice showed similar autoreactivity (Fig. 3a, c,
Supplementary Fig. 6a). Although most of SfCD4+Foxp3GFP−
derived hybridomas augmented PD-1 (but not CTLA-4) expres-
sion when stimulated by C57BL/6 DCs, this change could not
prevent these cells activation (Supplementary Fig. 7). SfCD4+
Foxp3GFP− derived hybridomas indiscriminately responded to
bone marrow or splenic DCs from SfC57BL/6 or C57BL/6 donors
(Supplementary Fig. 8a), and these responses did not change after
DCs were preloaded overnight with two organ-specific lysates
(Supplementary Fig. 8b), which suggests that most activating self-
peptides are naturally presented by DCs from healthy mice. In
contrast, <1% of SfCD4+Foxp3GFP− hybridomas responded to
DCs from C57BL/6 H2M−Ii− mice (Fig. 3c), which due to
impaired antigen processing express normal levels but mostly
empty class II MHC molecules (Ab)26. This last result demon-
strates that these hybridomas activation is triggered by autoanti-
gens bound to Ab. We also found that hybridomas generated
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Fig. 3 Hybridomas from SfCD4+Foxp3GFP− cells are activated by C57BL/6 DCs. a IL-2 production (red bars) and Nur77GFP expression (navy bars) by
representative hybridomas (#1-20) from SfTCRmini mice. Hybridomas were stimulated overnight by autologous DCs. The last 5 hybridomas (marked by
colored #1-5) were established from TCRmini mice and expressed the same five TCRs as first hybridomas #1-5 from SfTCRmini mice. Stars mark hybridomas
whose TCRs are also expressed by naive CD4+Foxp3GFP− cells in healthy TCRmini mice. b Sequences of TCRα CDR3 regions from hybridomas marked # 1-
5. For other TCRα CDR3 sequences see Supplementary Data 5. c One-third of hybridomas derived from CD4+Foxp3GFP− SfTCRmini effectors recognize
peptides presented by Abwt, but not empty Ab on DCs from H2-M-Ii− mice. Bars show % of responders of the total number of tested hybridomas from
each strain. d Top fifty dominant TCRs expressed by Sf effectors (CD4+CD44+CD62L−Foxp3GFP−) in LNs, and these TCRs frequencies on CD4
+Foxp3GFP− cells in the same organ in TCRmini mice (for sequences see Supplementary Data 6). Stars (*) mark TCRs also expressed by SfCD4+ cell
hybridomas that responded ex vivo to autologous DCs. e TCRs retrieved from autoreactive SfCD4+Foxp3GFP− hybridomas account for a major fraction of
TCRs expressed by peripheral CD4+Foxp3GFP− cells from healthy TCRmini mice. f IL−2 production and Nur77GFP expression by representative hybridomas
from SfC57BL/6 mice (#1–18) or healthy C57BL/6 mice (#19-23). Hybridomas were activated as indicated in (a). g IL−2 production and Nur77GFP
expression by representative CD4+Foxp3GFP− hybridomas from toxin-treated C57BL/6 Foxp3DTR/GFP(#1-20) or DT-treated control mice (#21-25) after
o/n co-culture with autologous DCs. Error bars are standard error across 3 SD replicas. h Percent of all tested hybridomas from Sf and control C57BL/6 or
toxin treated C57BL/6 Foxp3DTR/GFP that responded to activation by autologous DCs. Bars represent % of responders of total number of tested
hybridomas from each strain. Source data are provided in a Source Data file. Error bars shown as SD
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self-peptides presented in the same conditions (Supplementary
Fig. 8c–e). In addition, 29% of hybridomas established from
SfCD4+Foxp3GFP+ cells become activated following overnight
co-culture with C57BL/6 DCs (Supplementary Fig. 9), demon-
strating that abrogating Foxp3 function reveals comparable pro-
portions of autoreactive clones in both CD4+ subsets.
Next, we sequenced TCRs expressed by 232 autoreactive
hybridomas from SfCD4+Foxp3GFP− cells (Supplementary Data 5)
and compared their CDR3α regions to relevant repertoires from
SfTCRmini and TCRmini mice. First, we found that autoreactive
hybridomas expressed more than half of 50 most abundant TCRs
originally sequenced from SfCD4+Foxp3GFP− cells and that many
of the same TCRs were also expressed by CD4+Foxp3GFP− cells
from TCRmini mice (marked by an asterisk in Fig. 3d). Next, we
compared all CDR3α sequences from autoreactive hybridomas
from SfCD4+Foxp3GFP− cells to complete databases of CDR3α
regions retrieved from TCRmini repertoire of CD4+Foxp3GFP−
cells. As shown in Fig. 3e, we found that autoreactive TCRs
accounted for 34% of CDR3α regions sequenced from activated
CD4+Foxp3GFP− cells (overall 49% of all TCRs sequenced from
CD4+Foxp3GFP− cells), confirming that potentially pathogenic
clones constitute a substantial fraction of the TCR repertoire in
normal, healthy TCRmini mice. We also sequenced TCRs expressed
by 252 self-tolerant hybridomas from CD4+Foxp3GFP− cells and
discovered TCRs that were identical with previously sequenced
autoreactive TCRs from SfCD4+Foxp3GFP− hybridomas (examples
in Fig. 3a, b marked #1-5). Even though these shared TCRs had
matching specificities for self-peptides, only Sf-derived hybridomas
responded ex vivo to C57BL/6 DCs (Fig. 3a).
Finally, we identified three TCRs in a set of SfCD4+Foxp3GFP−
autoreactive hybridomas that matched TCRs on hybridomas
generated from prostate draining lymph node CD4+ T cells
isolated from TCRminiAire− mice. Aire− males develop non-
lethal prostatitis because defective presentation of Aire−con-
trolled self-peptides impairs negative selection in the thymus,
decreases elimination of autoreactive CD4+ effectors and restricts
development of tissue−specific Tregs27. In fact, CD4+Foxp3GFP−
hybridomas generated from TCRminiAire− mice responded only
to C57BL/6 DCs preloaded with prostate autoantigens (Supple-
mentary Fig. 10). These findings suggest that broad or tissue-
specific deficits of Tregs cells in Sf and Aire- mice impact
activation of CD4+ cells expressing identical TCRs specific for
ubiquitous and organ-specific autoantigens.
In C57BL/6 mice Tregs conceal many autoreactive CD4+
Foxp3− cells. In TCRmini mice we found that CD4+ cells from
autoimmune-prone Sf and healthy control mice (Fig. 3c) share
around 30% of autoreactive TCRs, but the relevance of this
observation to mice expressing wild type TCR repertoire
remained undefined. Therefore, we produced hybridomas repre-
senting CD4+Foxp3GFP− cells from SfC57BL/6 (or control
C57BL/6) mice and examined these hybridomas self-reactivity to
autologous DCs. As shown in Fig. 3f, h ~29% of hybridomas
established from SfC57BL/6 mice responded to C57BL/6 DCs,
whereas >1% of hybridomas derived from control C57BL/6 mice
showed detectable activation, though all tested hybridomas
similarly responded to activation by immobilized aCD3 MoAb
(Supplementary Figs. 5b and 6b). Thus, the abundance of auto-
reactive CD4+Foxp3GFP− clones is not artificially enhanced in
TCRmini mice as a result of the narrower repertoire. However, the
percentage of autoreactive CD4+Foxp3GFP− cells from SfC57BL/
6 mice could not be used to approximate the size of a respective
subset in healthy C57BL/6 mice because thymic involution and
duration of the disease in Sf mice supports differentiation and
clonal expansions of strain-specific, autoreactive cells. In addition,
cross-comparison of a representative number of autoreactive
TCRs shared by CD4+Foxp3− cells from SfC57BL/6 and C57BL/
6 will be cost-prohibitive.
To overcome these obstacles, we also immortalized CD4+
Foxp3GFP−cells from adult C57BL/6Foxp3DTR/GFP mice that for
5 consecutive days received diphtheria toxin injections, which
resulted in complete Tregs deletion and fatal autoimmunity on
day 6 or 7. In toxin injected C57BL/6Foxp3DTR/GFP mice over
80% of residual CD4+Foxp3GFP− cells had activated phenotype,
which was not observed in similarly treated control mice18. As
shown in Fig. 3g, h, Supplementary Figs. 5c and 6c, 33% of
hybridomas representing CD4+Foxp3GFP− from toxin-treated
C57BL/6Foxp3DTR/GFP mice were activated after overnight co-
culture with autologous DCs, demonstrating that repertoire of
C57BL/6 mice contains a significant portion of dormant,
autoreactive cells.
Recently it has been shown that pathogenicity of autoreactive
CD4+Foxp3GFP− cells in adult DT-treated C57BL/6Foxp3DTR/
GFP mice can be attenuated by an injection of pharmacological
inhibitor GSK503 that suppresses histone lysine methyltransfer-
ase Ezh2, a key enzymatic component of cytosolic polycomb
repressive complex 2 (PRC2)28. PRCP2 modulates TCR signaling
by interfering with TCR-mediated activation of MAPK/Erk and
IL2/IL2Rα expression. To determine if autoreactivity of CD4+
Foxp3GFP− hybridomas established from Tregs deficient mice
may reflect differences in epigenetic mechanisms regulating TCR
signaling, we pretreated these and control hybridomas with Ezh2
inhibitor prior to their stimulation by C57BL/6 DCs. As shown in
Supplementary Fig. 11, pretreatment with 5 μM GSK503
attenuated TCR-driven responses of autoreactive hybridomas to
autologous DCs but had no effect on these cells activation by
stimulants that bypass TCR/CD3 triggering. Therefore, Tregs
induced changes in epigenetic mechanisms that control TCR
activation in CD4+Foxp3− T cells can be reproduced ex vivo in
hybridomas derived from these cells.
Sf mice with Ab bound by single peptide succumb to auto-
immunity. Significant overlap between autoreactive TCRs
expressed by CD4+ cells in SfTCRmini and TCRmini mice can
result from intrinsic limitations of negative selection in the
thymus. Negative selection targets thymocytes expressing such
TCRs, but the highly diverse repertoires of TCRs and confronted
self-antigens impose spatial and temporal limits on the effec-
tiveness of deletion8,29,30. To improve the effectiveness of nega-
tive selection, we generated SfTCRmini mice that express class II
MHC (Ab) molecules covalently bound with a single autoantigen
(Eα) and Foxp3GFP reporter (now referred to as SfTCRminiA-
bEp). The diversity of natural self-peptides bound to Ab is
eliminated in these mice, whereas AbEp covalent complexes
naturally select and sustain diverse repertoires of CD4+Foxp3+
and Foxp3− cells31. Unexpectedly, while TCRminiAbEp mice
have a normal life expectancy31, SfTCRminiAbEp mice developed
rampant autoimmunity within the first weeks of life and had to
be euthanized at 6 weeks of age, significantly earlier than
SfTCRmini mice (Figs. 1a, 4a). As shown in Fig. 4b, SfTCRmi-
niAbEp had severe infiltrates in their skin and liver, the higher the
total number of activated and proliferating CD4+ effectors
(Fig. 4c–e, and Supplementary Fig. 1b) but fewer SfCD4+
Foxp3GFP+ cells (Fig. 4f, g). Thus, in SfTCRminiAbEp auto-
immune manifestations affected the same organs as in the ori-
ginal Sf mice despite that the former strain lacks expression of
tissue-specific antigens. Instead, the majority of autoreactive
SfCD4+Foxp3GFP− cells recognized the covalent AbEp com-
plexes as their targets, as SfTCRminiAb− mice lived much longer
before succumbing to the disease (Fig. 4a). In this latter strain,
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only a few SfCD4+ cells remained that underwent a selection on
non-classical MHC molecules but after 6–8 months these cells
expanded causing fatal autoimmunity.
An analysis of the TCR repertoire from SfTCRminiAbEp mice
using HTS (Supplementary Fig. 12a, b) showed that 60% of
dominant TCRs found on activated SfCD4+ effectors were also
found on CD4+ cells in lymph nodes of healthy TCRminiAbEp
mice. This high similarity was also indicated by the MII indexes
which showed overlaps of 40–65% between TCRs (Supplemen-
tary Fig. 12c). The overall diversity of TCRs on CD4+Foxp3GFP−
cells from SfTCRminiAbEp strain was higher than on correspond-
ing cells from control mice, due to increased contribution of rare
autoreactive clones (Supplementary Fig. 12d). Taken together,
these results show that intrathymic expression of single self-
peptide does not eliminate the need for Tregs-induced tolerance
for the same class II MHC/peptide complexes expressed in the
periphery. Instead and rather counterintuitively, it accelerated the
onset and progression of autoimmunity, suggesting that the
selecting autoantigen is recognized by self-selected CD4+ cells in
the periphery as a cognate autoantigen (see below).
The self-peptide recognized by autoreactive cells in SfTCRmini
AbEp mice is known because these mice express only covalently
linked AbEp complexes. To show directly that selecting self-
peptides can activate peripheral SfCD4+Foxp3GFP− cells and drive
autoimmunity, we converted these cells to hybridomas. One-third
of tested hybridomas responded in vitro to DCs presenting only
AbEp complexes, whereas only a few of these hybridomas
responded to DCs expressing Ab bound by other, covalently
linked AbEp63K peptide (Fig. 5a, b). This demonstrates that self-
reactive cells are highly specific for the original AbEp autoantigen.
Also, half of hybridomas that responded to DCs expressing other
AbEp63K complexes also responded to Ab− DCs, suggesting that
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Fig. 4 Single peptide SfTCRminiAbEp mice succumb to autoimmunity. a Survival curves of SfTCRminiAbEp, SfTCRminiAb- and corresponding TCRmini strains.
b Photomicrographs of H&E stained histological sections of organs from TCRminiAbEp (lower panel) and SfTCRminiAbEp mice (upper panel). For details see
Fig. 1b. Scale bar 400 μm. c, d Proportions of CD4+CD44+CD62L− cells in indicated mice. e The total number of CD4+ cells and f, g Proportions of
CD4+Foxp3GFP+ cells in indicated organs. All mice were 4-6 weeks old (n= 5–10). Unpaired t-test was applied, and statistical significance is indicated
where appropriate (*p < 0.05, **p < 0.01, ***p < 0.001, NS-not significant). Source data are provided in a Source Data file. Error bars show SD
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their TCRs cross-recognize non-classical MHC/autoantigen motifs
(Fig. 5b)31. As expected, >80% of CD4+ hybridomas from both
SfTCRminiAbEp and control TCRminiAbEp mice responded to
DCs isolated from C57BL/6 mice, because CD4+ cells isolated
from mice expressing a single type of Ab/peptide complexes are
not tolerant to other, endogenously processed self-antigens31. In
summary, these results show that Tregs are indispensable for the
induction of peripheral tolerance to autoantigen(s) recognized by
CD4+ cells, regardless of how abundantly the autoantigen is
expressed during thymic selection.
To investigate the mechanism behind accelerated onset and
progression of autoimmunity in SfTCRminiAbEp mice we
hypothesized that when the same class II MHC/peptide
complexes are abundant in the thymus and the periphery, more
autoreactive CD4+ cells require suppression by Tregs. To test this
hypothesis, we reconstituted lethally irradiated lymphopenic
AbwtTCRα–, AbEp63KTCRα– and AbEpTCRα– recipients with
T-cell depleted bone marrow from SfTCRminiAbEp mice. We
found that chimeras expressing AbEp complexes on thymic
epithelial and peripheral antigen-presenting cells succumbed to
autoimmunity first and had to be euthanized no later than
7 weeks after reconstitution. In contrast, recipients that originally
expressed only Ab bound with other covalently linked (AbEp63K)
or many self-peptides had the onset of autoimmunity delayed by
one to four weeks (Fig. 6a). The SfTCRminiAbEp to AbEpTCRα−
chimeras had a high proportion but low total number of CD4+
Foxp3GFP− effectors. Their TCRs resembled those expressed from
the corresponding subset in SfTCRminiAbEp mice, suggesting that
pathogenicity in both mice involves the same CD4+ clones
(Fig. 6b–d). This pathogenic repertoire had the lowest diversity of
TCRs of all compared chimeras, suggesting that these CD4+ cells
underwent the most rapid clonal expansions (Fig. 6e). In


























16 17 18 19 201 2 3 4 5 6 7 8 9 10 11 12 13 14 15







































n =  207
a
b
16 17 18 19 20
×102
×102







































Fig. 5 Positively selecting self-peptide activates SfCD4+ hybridomas. a IL-2 production (red bars) and Nur77GFP reporter expression (navy bars) by
representative hybridomas from SfTCRminiAbEp (#1-15) or control TCRminiAbEp (#16-20) mice stimulated by aCD3 MoAb (upper panel) or autologous
DCs expressing only AbEp complexes (lower panel). For TCRα CDR3 sequences see Supplementary Data 9. Stars mark hybridomas whose TCRs are also
expressed by naive CD4+Foxp3GFP− cells in healthy TCRminiAbEp mice. b Percentage of hybridomas from SfTCRminiAbEp mice that responded to DCs
expressing endogenous self-peptides (Abwt), covalently linked autologous (AbEp) or non-autologous (AbEp63K) self-peptide, or lacking Ab expression
(Ab−). Source data are provided in a Source Data file. Error bars show SD
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comparison, AbwtTCRα− recipients manifested the slowest onset
and progression of autoimmunity. Lastly, hybridomas established
from autoimmune effectors retrieved from AbwtTCRα– or
AbEp63KTCRα– recipients responded more frequently to Abwt
or Ab63K than AbEp complexes, documenting these TCRs bias
toward the positively selecting ligands (Fig. 6f).
In the following experiment, we adoptively transferred CD4+
Foxp3GFP− from SfTCRminiAbEp mice to AbEpTCRα– or
AbEp63KTCRα– recipients. In these settings, SfCD4+ cells had
been in contact only with AbEp complexes prior to injection. As
shown in Fig. 6g, while the AbEpTCRα– recipients quickly
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survived until the end of the experiment (over 16 weeks). These
results indicate that the SfCD4+ repertoire recognizes the self-
selecting AbEp complexes as cognate antigens and has impaired
ability to sense other Ab/peptide ligands. Furthermore, when
identical lymphopenic AbEpTCRα− or AbEp63KTCRα− recipi-
ents received an adoptive transfer of naive CD4+ cells from
healthy TCRminiAbEp donors, both types of host mice developed
lethal autoimmunity (Fig. 6g). This last result shows that
transferred alone CD4+Foxp3GFP− cells from healthy TCRminiA-
bEp mice to lymphopenic recipients expressing exclusively Ep or
Ep63K analog caused autoimmunity.
Identical CD4+Foxp3GFP− cells from Sf and healthy mice have
distinctive gene signatures. We have shown that autoreactive
CD4+Foxp3GFP− cells from SfTCRmini mice and corresponding
cells from TCRmini mice share many identical TCRs that recog-
nize self-peptides as agonists, but the role of these mutual CD4+
clones in autoimmunity and organ damage remain unde-
termined. Therefore, next we examined the transcriptional
signatures of hundreds of individual SfCD4+Foxp3GFP− cells and
their counterparts from control TCRmini mice with a focus on
clones expressing the same TCRs to determine if former cells
molecular signatures are consistent with pathogenic autoimmune
effectors.
For this purpose, we sorted CD4+Foxp3GFP−CD44+CD62L−
subsets from SfTCRmini and TCRmini mice and encapsulated over
1500 single cells in microfluidic droplets using a 10× Chromium
Controller for parallel scRNAseq analysis and TCR sequencing32.
Approximately 780 scRNAseq profiles from individual cells of Sf
mice and 480 from control mice passed quality control and
normalization (see Methods for details). From each of these single
cells, we detected an average of 1750 different genes and
separately amplified and sequenced their TCRα
CDR3 sequences. Next, we performed a t-distributed stochastic
neighbor embedding (t-SNE) analysis, which in scRNAseq is
often used to separate cell subpopulations according to their
distinctive genetic signatures. This analysis showed that SfCD4+
effectors had a plot distribution distinct from most activated but
dormant CD4+Foxp3GFP− cells from control TCRmini mice. Over
80% of individually examined SfCD4+ cells formed two separate
clusters that encompassed 307 and 377 individual cells respec-
tively, whereas 70% (361 cells) of corresponding cells from
TCRmini mice fell into a third distinct cluster (Fig. 7a). Thus, the
three main clusters were dominated by either Sf or control-
derived CD4+Foxp3− cells, with only a few cross-contaminants
(Fig. 7a). The remaining CD4+Foxp3− cells (96 cells from
SfTCRmini and 83 cells from controls) grouped in a fourth cluster.
Multiple significantly overexpressed genes (p < 0.001) could be
associated with only one cluster, although the majority of genes
were universally represented at comparable levels in all clusters
(Fig. 7a–c). For example, the expression of transcription factor
Eomes, granzymes (k and b), chemokine ligands (CCL 3, 4, and 5),
inhibitory and signal regulators (Ctla2a, Klrg1, Rgs1, SAP, Arap2,
TIGIT, Sh2d2a, Fyn, Prkch, Dusp2, and CD7) and integrin Itga4
were all highly expressed by most cells within the first cluster
(marked in blue) that almost exclusively encompassed half of the
Sf-derived effectors (Fig. 7a, b). Overexpression of granzymes,
perforin, CCL3-5, and Eomes is consistent with key functional
characteristics of cytotoxic, pathogenic, CD4+ effectors found in
multiple sclerosis and systemic fibrotic sclerosis, underlining the
autoreactive features of these clones33,34.
The second cluster (marked in yellow) that encompassed most
of the other half of SfCD4+ effectors had discriminatively high
expression of interferon-induced Ifitm1-3, Igtp, and Cish. Less
prominently but also significantly overexpressed (from p < 0.01 to
p < 0.05) were IL7R, Pim1 kinase, Lgals3, Cxcr6 and GATA3, the
expression of which in effector CD4+ cells have been linked to
altered TCR signaling, inflammation and autoimmune
diseases35,36 (Fig. 7). Finally, the high expression of Nrp1 and
FR4 (Izumo1r) suggested that these cells activation may be
impacted by anergy37.
The majority of activated CD4+Foxp3GFP− cells from control
TCRmini mice formed a separate third cluster (marked in green).
Genes discriminately expressed by this subset include Stmn1,
S100a4, Hmbg2, Vim, Anxa2, Ass1 (p < 0.001), which are
collectively known to be involved in cytoskeleton reorganization,
T cell activation and cell cycle regulation (Fig. 7a, b). The fourth
and final cluster (marked in red) grouped activated cells from
both strains and was enriched in cells overexpressing Ly6c and
CD74 (p < 0.01) (Fig. 7).
Differential expression of selected (granzyme B vs Tnfrsf4 and
Ly6c vs ICOS) genes was confirmed using flow cytometry, in
which staining recapitulated the original split of SfCD4+ effectors
into two separate clusters with differential expression of these
markers (Supplementary Fig. 13a). Furthermore, overall low
expression of Nur77 and moderate levels of CD5 (detected in
individual CD4+ and SfCD4+ cells by scRNAseq) correlated with
expression of the Nur77GFP reporter and staining by monoclonal
antibodies (MoAbs) specific for CD5 (Supplementary Fig. 13b).
Although peripheral SfCD4+CD44+CD62L− and CD4+CD44+
CD62L− cells express similar levels of Nur77GFP+ and CD5+,
ex vivo former subset responded to lower concentrations of aCD3
MoAb, suggesting these cells higher sensitivity for weak TCR
triggering (Supplementary Fig. 14).
To show that CD4+ cells expressing identical TCRs remain
inactive in TCRmini mice, but in SfTCRmini mice convert to
autoimmune effectors, we color-coded only these cells on t-SNE
plots according to their origin or unique TCR (Fig. 7d, e). Overall,
we found 23 TCRs (encoded by 63 different nucleotide
sequences) shared by CD4+Foxp3GFP−CD44+CD62L− cells in
both mice. These TCRs were expressed by 176 individual cells
(123 from SfTCRmini and 53 from TCRmini), and more than half
of them were also expressed by hybridomas established from
SfCD4+Foxp3GFP−CD44+CD62L− cells (Supplementary
Data 11). Most CD4+ cells expressing these common TCRs from
TCRmini mice co-localized on 2D-visualized t-SNE plots in the
third cluster, the transcriptional signature of which was most
compatible with an antigen-experienced but dormant phenotype.
In contrast, most cells expressing identical TCRs from SfTCRmini
mice gathered within either the first or second cluster (Fig. 7d, e).
Fig. 6 Thymic and peripheral expression of the same self-peptide accelerates autoimmunity in Sf chimeras. In BM chimeras same donor provided
hematopoietic cells expressing only AbEp complexes whereas radioresistant thymic epithelial cells expressed different (AbEp63K or Abwt) or the same
(AbEp) complexes. a Survival curves of AbEpTCRα−, AbEp63KTCRα− and AbwtTCRα− mice reconstituted with bone marrow (BM) from SfTCRminiAbEp
mice. b Proportions of CD4+ and CD4+CD44+CD62L–Foxp3GFP− cells in different radiation chimeras. c Dominant TCRs on CD4+ cells in indicated
chimeras (see Supplementary Data 10 for sequence. Unpaired t-test. d Similarity indices (MII) for TCR repertoires from SfTCRminiAbEp mice and various
chimeras. e Diversity index (REF) for the repertoire of Tregs from different chimeras. f Percent of hybridomas established from CD4+Foxp3GFP− cells
from indicated chimeras that responded to Abwt DCs. g Survival curves of AbEpTCRα– or AbEp63KTCRα– recipients of adoptive transfer (AT) of CD4+
Foxp3GFP− cells from SfTCRminiAbEp mice. Source data are provided in a Source Data file. Error bars show SD
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Further analysis of signature genes using exclusively scRNAseq
data from single CD4+CD44+CD62L−Foxp3GFP− cells expres-
sing common TCRs showed that cells from SfTCRmini mice
distinctively expressed genes linked to autoimmunity and
cytotoxicity (Gzmk/b, Eomes, Ctla2a, Cst7). In contrast, the gene
signature of corresponding cells expressing the same TCRs from
TCRmini mice reflected transcriptional traits of latent CD4+ cells
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Fig. 7 Analysis of DE genes in individual SfCD4+Foxp3GFP− and CD4+Foxp3GFP− effectors. a 2D visualization of t-SNE plot separating peripheral CD4+
CD44+CD62L−Foxp3GFP− cells from Sf and healthy TCRmini mice. a Heatmap of differentially expressed (DE) genes in clustered CD4+Foxp3GFP−
cells from SfTCRmini and TCRmini mice. Grid cells are colored by a gene’s log2 fold change. c Violin plots show the expression of a selected set of DE
expressed genes among the different clusters. d 2D visualizations of t-SNE projections of individual CD4+Foxp3GFP− cells from TCRmini (orange) and
SfCD4+Foxp3GFP− from SfTCRmini (purple) mice that shared 23 common TCRs. e 2D imaging of t-SNE dimensionality reduction plot with 23 different
TCRs shared by CD4+ single cells in both studied strains. The same color (but not gray) in the plot represents the identical TCR clonotypes. Sequences of
TCRα CDR3 regions, coding color and their frequencies in each strain are listed in Supplementary Data 11. f Volcano plot shows aggregate of DE genes of all
shared clonotypes CD4+Foxp3GFP− cells from SfTCRmini and TCRmini control mice. Genes most relevant to these cells distinctive functional status are
specified. Source data are provided in a Source Data file
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in healthy mice many CD4+Foxp3− appearing as quiescent
express autoreactive TCRs that will direct autoimmune responses
and self-tissues injury in these cells if peripheral tolerance is
compromised.
Discussion
Comparison of TCR repertoires of Sf and healthy mice strongly
suggests that the proportion of potentially autoreactive CD4+
cells is approximately one-fold higher than the highest estimates
previously published15, but not far from estimates of autoreactive
CD4+ cells in transgenic mice expressing model autoantigen. In
these studies, up to 30% of thymocytes that expressed TCRs
specific for model self-peptide survived negative selection and
moved to the periphery7,30. The final estimate of autoreactive
CD4+ cells controlled by peripheral tolerance may exceed 30% of
all CD4+ cells as downregulation of inhibitory co-receptors on
SfCD4+ cells allows for expansion of autoreactive T cell clones
and exacerbated disease symptoms38–40. Our data is consistent
with the results of the previous study where depletion of Foxp3+
cells in adult mice using DT injections led to accelerated onset of
multiorgan, lethal autoimmunity and lymphoproliferation18. This
report postulated that a very high proportion of CD4+Foxp3 cells
is continuously controlled by Tregs. Thus, both unmanipulated
C57BL/6 and TCRmini mice consistently show a high prevalence
of autoreactive CD4+Foxp3− cells that were not physically
deleted or silenced and need to be controlled by the Tregs.
To show that a substantial proportion of CD4+ cells is not only
self-reactive but also pathogenic, we isolated activated effector
cells infiltrating various organs from Sf mice and then examined
their TCRs and responses to autologous DCs ex vivo. Self-
reactivity of hybridomas derived from Sf mice (Foxp3GFP− and
Foxp3GFP+) was somewhat surprising since, in general, hybri-
domas do not inherit parental CD4+ cell effector features like
Foxp3 expression or Th1/Th2 effector function. This is because
intertypic hybrids of equal ploidy (mature CD4+ cell fused with
thymoma) fail to express lineage specific traits of either parent41.
Comparable proportions of hybridomas representing CD4+
Foxp3− cells from Sf and adult DT-treated C57BL/6Foxp3DTR/
GFP mice were self-reactive, demonstrating that it is not a unique
feature of TCRmini repertoire22. However, hybridomas can inherit
epigenetically regulated features that influence TCR signaling
pathways, suggesting that future studies investigating these cell
lines autoresponses should incorporate a detailed analysis of the
epigenetic landscape.
Our findings support the previous report that some of the key
autoantigens that trigger pathogenesis in Sf mice have ubiquitous
expression42. We found that around 20% of autoreactive TCRs
expressed by dormant CD4+Foxp3− cells had high functional
affinities for these common autoantigens, as reflected by an
average fifty-fold increase in Nur77GFP expression and measur-
able IL-2 secretion by hybridomas established from these cells
(Figs. 3 and 5). Relatively high incidence of CD4+Foxp3− cells-
that express high(er) affinity, potentially pathogenic TCRs
in the peripheral repertoire is therefore significant for our
understanding of mechanisms of thymic selection, role of TCR in
CD4+ T cell lineage commitment and common features of
autoimmune diseases. We propose that the current paradigm of
interdependence of central and peripheral tolerance should better
emphasize Tregs control over many rather than few autoreactive
peripheral CD4+ cells and revisit the role of agonist peptides in
positive selection of CD4+Foxp3− cells (for the proposed model
see Fig. 8).
Expression levels of the Nur77GFP reporter, which is propor-
tional to the strength of TCR signaling, were similar in patho-
genic SfCD4+ effectors and activated, peripheral CD4+ cells from
healthy mice, suggesting that on average, functional affinity of
























Fig. 8 Abundance of autoreactive CD4+ T cells-current and proposed hypotheses. a Current paradigm: Only thymocytes that TCRs weakly bind class II
MHC/ self-peptide complexes differentiate as CD4+Foxp3− cells (gray dots). Thymocytes that express autoreactive TCRs are deleted by negative
selection (black dots) or become CD4+Foxp3+ Tregs (blue dots). • Negative selection infrequently misses CD4+Foxp3− cells with autoreactive TCRs. • In
the periphery, Tregs control few (1-4%) autoreactive CD4+Foxp3− cells. In Tregs deficient mice these rare CD4+Foxp3− cells clonally expand causing
autoimmunity. • Tregs only complement central tolerance. • Autoreactivity is a nuance of TCR repertoire of peripheral CD4+Foxp3− cells but is a common
feature of CD4+Foxp3+ repertoire. b Proposed model: Approximately 1/3 of mature CD4+Foxp3− cells express autoreactive TCRs. A considerable portion
of CD4+Foxp3− cells are selected by agonist self-peptides. • Negative selection fails to delete a substantial portion of thymocytes expressing potentially
autoreactive TCRs. • In Tregs deficient mice autoimmunity involves polyclonal activation of CD4+Foxp3− cells by ubiquitous self-peptides. • Central
tolerance and Tregs have an equal role in preventing autoreactivity. • Autoreactive TCRs are expressed at similar frequencies by CD4+Foxp3− and CD4+
Foxp3+cells. TCR self-reactivity has a limited impact on CD4+ cells lineage commitment
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in Sf mice compared to TCRs expressed by antigen-experienced
CD4+Foxp3− cells in healthy mice. We also found that
SfTCRmini mice have few CD4+Foxp3− cells co-expressing FR4
and CD73, which in C57BL/6 mice mark CD4+ anergic cells,
suggesting that Tregs may be also involved in the induction of
anergy37 (manuscript in preparation). In contrast, SfTCRmini
mice had twice as many CD4+Foxp3−PD-1hi cells than control
mice, suggesting that in some autoreactive clones adversely acti-
vated by self-antigens, intrinsic mechanisms of peripheral toler-
ance attempt to compensate for the lack of functional Tregs.
Reportedly, mice with reduced Foxp3 expression in Tregs
developed multiorgan autoimmunity when Tregs also lacked PD-
1 expression, suggesting that PD-1 inhibition non-redundantly
controls an additional pool of autoreactive CD4+ cells39.
Our results also demonstrate that potentially autoreactive CD4+
Foxp3− cells express abundant TCRs that have been speculated to
recognize ubiquitous autoantigens (Fig. 2)43. Some of these
dominant TCRs were also found in Ab-deficient Sf and healthy
mice, suggesting that the differentiation and activation of these
clones is not strictly dependent on self-antigens presented by class
II MHC. These Ab independent clones caused autoimmunity and
death of SfTCRminiAb- mice after 24 weeks rather than 8–10 weeks
as observed in SfTCRmini mice, highlighting the dominant role of
self-antigens presented by class II MHC in Sf autoimmunity.
Similarly, hybridomas established from SfCD4+Foxp3GFP+ cells
were also autoreactive, but the significance of these cells in auto-
immune diseases remains to be elucidated further44.
Many studies have concluded that Tregs are particularly
important for the induction of tolerance to epitopes from tissue-
restricted antigens or neoantigens that are absent or poorly
represented in the thymus. Unexpectedly we found that Sf mice
lacking a diverse range of self-peptides bound to Ab suffer from
accelerated autoimmunity and very severe skin inflammation.
The fact that major manifestations in SfTCRminiAbEp mirrored
those in SfC57BL/6 mice shows that organ-specific epitopes are
not critical to drive autoimmune T cells activation and Sf
pathogenesis. The Ep peptide (originally described as Eα(52-68))
is a naturally abundant self-peptide presented by Ab in the
thymus and the periphery45. We anticipated that SfTCRminiA-
bEp mice may better tolerate Tregs dysfunction, as central tol-
erance should have eliminated most of the thymocytes with
AbEp-specific TCRs. On the other hand, in these mice the same
self-peptide is not only facilitating both positive and negative
selection but is broadly expressed on all class II MHC positive
cells in the periphery and can activate self-selected peripheral
CD4+ cells. Overall these results suggest a scenario in which
lack of functional Tregs leads to polyclonal activation of CD4+
Foxp3− cells that often recognize abundant self-peptides as
autoantigens.
Methods
Mice. Animal breeding and experiments were performed in a specific pathogen-
free animal facility in compliance with the protocol approved by the Georgia
State University Institutional Animal Care and Use Committee, and we com-
plied with all the ethical regulations. Both TCRmini, TCRminiAbEp and C57BL/
6Foxp3GFP mice were previously described (Pacholczyk 2006, and Jax mice
023800). To introduce scurfy mutation in TCRminiFoxp3GFP and TCRminiAbEp,
mice were crossed with SfC57BL/6 females (Jax 004088) and then intercrossed
for 10-12 generations. For adoptive transfer experiments and bone marrow
chimeras production TCRα− (Jax mice 002116), AbEpTCRα− and
AbEp63KTCRα−31 were used. TCRminiNur77GFP mice were obtained by
crossing TCRmini with C57BL/6Nur77GFP reporter mice (Jax mice 016617).
TCRminiAire−, H2M− Ii−, and strains were described previously18,46,47. To
deplete Tregs, C57BL/6Foxp3DTR/GFP mice were injected with diphtheria toxin
(50 μg/kg) on five consecutive days18. Animals were 6–10 weeks old at the time
of experiments (unless otherwise specified) and consisted of males and less often
females because matching Sf heterozygote males (Sf mutation in on X chro-
mosome) were used.
Isolation of T cells from lymphoid and nonlymphoid organs. Single-cell sus-
pensions were prepared from inguinal and mesenteric lymph nodes by mechanical
disruption and passed through 100 μm filter (Corning). Colonic lamina propria
T cells were isolated, as previously described48. Briefly, colons were opened long-
itudinally and contents were flushed with ice-cold Hanks balanced salt solution,
HBSS (Cellgro). Each colon was cut into small pieces and washed with HBSS
solution supplemented with 5% FCS (HyClone) and 2 mM EDTA at 37 °C. A
single-cell suspension was obtained after treatment with Collagenase D (1.0 mg/ml)
and DNase I (0.1 mg/ml) (both from Roche). A purified and concentrated sus-
pension of lamina propria lymphocytes was obtained after centrifugation on Per-
coll (GE Healthcare) gradient (45% and 70%). The interface, enriched in
leukocytes, was collected and used for experiments. Lungs and liver were harvested,
and lymphocytes were isolated by enzymatic digestion for 20 min, using Col-
lagenase D (1.0 mg/ml) and DNase I (0.1 mg/ml) (both from Roche) at 37 °C. For T
cell enrichment, Lymphocyte Separation Medium (Corning) was used. The inter-
phase was collected and used for further analysis.
Flow cytometry and cell sorting. Monoclonal antibodies conjugated with dif-
ferent fluorescent dyes were purchased from BioLegend, BD or eBioscience unless
otherwise listed in the Key Resources Table. Cell surface staining with monoclonal
antibodies and intracellular staining for CTLA-4 was done by standard procedures.
Samples were analyzed using a CytoFLEX Flow Cytometer (Beckman) or FACS-
Canto (Becton Dickinson) and data were processed with FlowJo v10 (FlowJo, LLC).
Cells were sorted using Sony SH800 (Sony) and MoFlo cell sorter (Beckman
Coulter) with purity above 98%. For the gating strategy see Supplementary Fig. 15.
Synthesis of cDNA libraries and high throughput sequencing. Preparation of
the library for single-cell was performed from flow-cytometer-purified T cells (purity
> 99%), as previously described48. Single CD4+Foxp3GFP+ and CD4+Foxp3GFP−
T cells cells were sorted into 96-well plates from different organs. cDNA was syn-
thesized using MMLV reverse transcriptase (Promega) and random hexamers
(Invitrogen) followed by two rounds of PCR via Perfect Taq Polymerase (5 PRIME).
Products of CDR3 Vα chain obtained in the second PCR reaction were sequenced.
For Ion Torrent high throughput sequencing Cα specific cDNA was synthesized,
amplified and CDR3 region of TCRα chain was sequenced48. For two-way Illumina
HTS library RNA was isolated from the sorted subsets using the RNeasy Mini Kit
(Qiagen) according to the manufacturer’s procedure. Synthesis of the first com-
plementary DNA (cDNA) strand was performed with a primer specific for the TCR
Cα region (5′-TCGGCACATTGATTTGGGAGTC-3′) using Superscript III cDNA
synthesis kit (Invitrogen). Incorporation of Illumina sequencing primers together with
the bar-coding of DNA material was performed during 2 step PCR amplification
using Accuprime Taq Polymerase (Invitrogen). The first step involved amplification
and incorporation of Illumina fragment, followed by product purification (NucleoFast
96 PCR (Macherey-Nagel) - removal of primers from previous steps). The PCR
reaction was carried out with a pair of primers specific to the Vα2 (5′-ACACTC
TTTCCCTACACGACGCTCTTCCGATCTACAGACTCTCAGCCTGGAGACTCA
GCT-3′) and Cα (5′-GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTTTAA
CTGGTACACAGCAG-3′) regions of the TCRα chain. During the second PCR step
Illumina indexes and adaptors (index 1 with i7 adaptors: 5′-CAAGCAGAAGACG
GCATACGAGATXXXXXXXXGTGACTGGAGTTCAGACGTGTGCTCTTCCG
ATC-3′ and index 2 with i5 adaptors: 5′-AATGATACGGCGACCACCGAGATCTA
CACXXXXXXXXACACTCTTTCCCTACACGACGCTCTTCCGATCT-3′) where
italic font marks an Illumina adaptor sequence. Quality of the library was confirmed
by servicing cores using Kapa PCR, Qubit and Fragment Analyzer (High sensitivity
NGS fragment analysis) before running it on the Illumina platform. The PCR product
was sequenced using the MiSeq Illumina PE250 platform either by Genomics Core at
Arizona State University or by Georgia Genomics and Bioinformatics Core at The
University of Georgia.
Bone marrow chimeras. BM was obtained by flushing donor humerus, tibia, and
femur. BM was then RBC lysed and T cell-depleted by labeling cells with bioti-
nylated anti-CD4 and anti-CD8 and anti-biotin microbeads, followed by magnetic
cell separation using MS columns (Miltenyi Biotech). In vitro 10 × 106 cells were
injected iv into 750 rad lethally irradiated (RS 2000 Biological Research Irradiator),
lymphopenic hosts: AbwtTCRα−, AbEpTCRα− and AbEp63KTCRα− mice. Mice
were maintained on antibiotic water (1 mg/ml vancomycin) four days prior and
one week after transplantation. Mice weight was monitored every 3 days and
euthanized when the bodyweight reached 80% of starting weight.
Adoptive transfer of Sf CD4+ T cells. In total 1 × 106 of naive TCRminiFoxp3GFP−
CD44−CD62L+ T cells were injected iv to individual 6-week-old, lymphopenic
AbEpTCRα− or AbEp63KTCRα− recipients. Bodyweight was monitored every 3 days.
Animals that reached a humane endpoint were killed, and no later than after
16 weeks.
Histology. Tissues were excised and immediately placed in 10% buffered formalin
(Fisher) for at least 48 h to ensure enough penetration, then processed with
Excelsior ES tissue Processor (Thermo). Tissues were embedded in paraffin blocks
and 4 μm sections were cut with Shandon Finesse 325 Manual Microtome
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(Thermo). Slides were stained with hematoxylin and eosin (both from Fisher)
according to a standard protocol. Slides were analyzed by an experienced clinical
pathologist (N.S.) in a blinded manner. At least three fragments of each tissue were
photographed (EVOS FL Auto microscope (×10 magnification) equipped with
Pearl Scope software (Fisher). Scale 0-4 was applied: 0-no inflammation (no dis-
cernible inflammation), 1-mild (small, focal focus of inflammation), 2-moderate
(small, multiple foci of inflammation), 3-strong (multiple large foci of inflamma-
tion), and 4- severe (significant inflammation with parenchymal destruction). Data
were analyzed with Origin 2017 (OriginLab).
Hybridoma production and testing. CD4+ hybridomas were prepared as repor-
ted49. The fusion partner was a new variant of BWα−β− thymoma that has been
stably transfected with Nur77GFP reporter (BWNur77GFP, manuscript in prepara-
tion). For testing, 2 × 105 hybridomas were mixed with 2.5 × 104 BMDCs (6-day old
bone marrow cells elicited with GM-CSF (5 ng/ml), >80% CD11c+MHCII+) in
round-bottom wells. As a control, hybridomas were activated with plate-bound aCD3
(10 μg/ml) MoAb or PMA (50 ng/ml) and Ionomycin (0.5μg/ml). After 16 h of
Nur77GFP upregulation was assessed by FACS in gated CD4+Vα2+ cells. Super-
natants were saved for IL−2 detection by HT-2 assay49. In selected experiments,
hybridomas representing CD4+Foxp3GFP− cells from DT-treated Foxp3DTR/GFP mice
or controls were preincubated with GSK503 inhibitor at 5 μM for 24 h before use for
activation assay. This preincubation does not change expression of TCR, CD4 or class
II MHC.
Preparation of lysates from non-lymphoid tissues. Tissues were digested with
collagenase D (1.0 mg/ml) and DNaseI (0.1 mg/ml) (both from Roche) for 30 min
at 37 °C, washed twice with PBS and resuspended in sonication buffer (50 mM Tris,
pH 8.0, 0.05% v/v Tween 20 (all from Fisher), and 1x protease inhibitors (Halt
Protease Inhibitor Cocktail, Fisher). Cells were sonicated on ice with Branson
sonicator (duty 30, output 2; 1-s burst, 10-s rest, 3 min total). Insoluble material
was removed by centrifugation (4 °C, 15 min, 10,000 × g). Protein content was
measured with the BCA kit (Fisher).
scRNAseq and TCR sequencing. Single-cell suspensions were prepared from
lymph nodes by mechanical disruption through nylon mesh, washed, counted and
stained with appropriate antibodies. CD4+CD44+CD62L−Foxp3GFP− and CD4+
Foxp3GFP+ populations were obtained by sorting with SH800 sorter (Sony) with
purity > 98%. Next cells were subjected to in Gel Bead Emulsion using Chromium
10x Genomics controller according to manufacturer guidelines. To accomplish
parallel scRNAseq and TCR sequencing after cDNA amplification, the con-
centration of each sample was measured using Bioanalyzer (Agilent). Next, up to
50 ng cDNA was used for 5′ gene expression library construction and 1/16 of this
amount for TCR V(D)J target enrichment step (using custom-designed primers).
To prepare the cDNA libraries for 10x Genomics Chromium controller we used the
single-cell 3′ v2 kit. QC for both libraries was done using Bioanalyzer (Agilent) at
the GSU Molecular Biology Core and later confirmed by TapeStation 2200 (Agi-
lent) at the University of Florida Interdisciplinary Center for Biotechnology
Research. scRNA sequencing was done on Illumina NextSeq500 (1 × 150) machine
with a sequencing depth of at least 50,000 reads per cell, whereas TCR library on
MiSeq (2 × 150) machine with a sequencing depth of at least 5000 reads per cell.
Both were performed at the University of Florida Interdisciplinary Center for
Biotechnology Research (Gainesville, FL).
Processing of scRNAseq data. Illumina sequencer base call files (BCL) were
processed and demultiplexed with CellRanger (v2.2) that used Illumina conversion
software bcl2fastq2 (v2.2). FASTQ files were processed using CellRanger software,
which performed alignment, filtering, barcode counting, and UMI counting.
Single-cell V(D)J sequences were generated with VDJ function of CellRanger using
a custom-made VDJ reference genome. For single-cell expression profiling, reads
were aligned to the mouse genome (mm10-2.2), with CellRanger counts software,
for their assignment as murine sequences. Low-quality cells were excluded in an
initial quality control (QC) step by removing genes expressed in fewer than three
cells. Also, cells with less than 200 genes expressed or that express >2500 genes
were removed. We also removed cells that had >0.05% of mitochondrial-associated
genes among their expressed genes. We then normalized the data using log nor-
malization and scale factor 10,000 using the Normalize Data function in Seurat. To
identify the differentially expressed features we used the Find Markers function
with min.pct argument set to 0.25, which filters out genes expressed in <25% of the
cells. PCA, t-SNE and graph clustering were produced using Cell Ranger’s pipeline
with default settings. Analysis of DE genes downstream was performed using
cLoupe (10× Genomics) and R package Seurat software50.
Quantification and statistical analysis. For survival analysis, we used Kaplan-
Meier survival curves and p values were calculated using Log Rank Test. For TCR
analysis, only CDR3 regions found more than five times in each population per
organ and mouse were analyzed. TCRα CDR3 species frequencies were obtained
from 2 biological replicates each with 2 technical replicates sequenced both ways.
These frequencies were used to determine the number of TCRVα2 CDR3 clono-
types. Statistical significance of the results was performed using Origin Pro (Origin
Lab). The analysis was performed using independent samples t-test or a paired
sample Student t-test as appropriate. The results were expressed as the mean ± SD
unless stated otherwise. *p ≤ 0.05, **p < 0.01, ***p < 0.001 as statistically significant,
NS-considered as statistically nonsignificant. For the comparative analysis of the
overlap, a mutual information index (I-index) was used as defined25. Diversity was
quantified using the effective number of species (ENS) and presented in the form of
diversity profiles (for definitions see25).
Software availability. Origin 2017 (OriginLab), GraphPad Prism (GraphPad
Software) and Adobe Illustrator (Adobe) were used for graphical and statistical
analysis (available commercially). The Seurat R package v3.0 was used for scRNA
seq and cLoupe (10X Genomics). High throughput sequencing data was processed
using custom made Python-based TCR extraction tool and database are available
upon request.
Reporting Summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
scRNAseq sequencing data generated in this study have been deposited in the Gene
Expression Omnibus under the primary accession code: =NCBI under the accession
number PRJNA575202. The source data underlying Figs. 1a, b, d, e, g, 2a–d, 3a, c, d, f, g,
h, 4a, b, d, e, g, 5a, b, 6a–g, 7b and Supplementary Figs. 1–5, 7–13 are provided as a
Source Data file. All other data are available on request from the corresponding author.
Material Transfer Agreement will be used to transfer any data that can be shared.
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